These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults. Setyawan J, Hodgkins P, Guérin A, Gauthier G, Cloutier M, Wu E, Erder MH. J Med Econ; 2013 Oct; 16(10):1203-15. PubMed ID: 23937642 [Abstract] [Full Text] [Related]
45. Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder. Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L, 304 Study Group. CNS Spectr; 2009 Oct; 14(10):573-85. PubMed ID: 20095369 [Abstract] [Full Text] [Related]
46. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Findling RL. Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941 [Abstract] [Full Text] [Related]
49. Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine. Kay GG, Michaels MA, Pakull B. J Atten Disord; 2009 Jan; 12(4):316-29. PubMed ID: 18815438 [Abstract] [Full Text] [Related]
50. Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate? Wigal SB, Jun A, Wong AA, Stehli A, Steinberg-Epstein R, Lerner MA. Postgrad Med; 2010 Sep; 122(5):27-34. PubMed ID: 20861585 [Abstract] [Full Text] [Related]
51. A pilot study of stimulant medication for adults with attention-deficit/hyperactivity disorder (ADHD) who are parents of adolescents with ADHD: the acute effects of stimulant medication on observed parent-adolescent interactions. Babinski DE, Waxmonsky JG, Waschbusch DA, Humphrey H, Alfonso A, Crum KI, Bernstein M, Slavec J, Augustus JN, Pelham WE. J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):582-5. PubMed ID: 25386742 [Abstract] [Full Text] [Related]
58. Adverse events in medication treatment-naïve children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate. Wigal SB, Wong AA, Jun A, Stehli A, Steinberg-Epstein R, Lerner MA. J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):149-56. PubMed ID: 22372513 [Abstract] [Full Text] [Related]